Tesofensine
aka NS2330
GLP-1 / Metabolic
Mechanism
Tesofensine is a small-molecule triple monoamine reuptake inhibitor (serotonin, norepinephrine, dopamine) — NOT a peptide. Originally developed by NeuroSearch for Parkinson's and Alzheimer's disease (which it failed to benefit) and repositioned for obesity by Saniona. Not FDA-approved in the US.
Identification
Vendors selling Tesofensine
No vendor listings on file yet.
Research
No citations on file yet.